Jenny Shliozberg

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/b4de2cd0-35dc-11ed-82c6-41b469a7b495.jpg

First Name

Jenny

Last Name

Shliozberg

NPI

1174603971

Faculty ID

1191

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

3597

Biography

<p>Jenny Shliozberg, MD, is an attending physician at the Children&rsquo;s Hospital at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is in food allergy, hereditary angioedema (HAE), asthma, rhinitis, oral allergy syndrome and chronic urticaria. She frequently conducts food and drug challenges and has cared for HIV-positive and immunodeficient patients for the last 35 years.
</p><p>After earning her Doctor of Medicine at First Pavlov Medical University in St. Petersburg, Russia, Dr. Shliozberg continued with her postgraduate training at the same institution, completing her internship in obstetrics and gynecology followed by an ambulatory obstetrics and gynecology clinic. She later came to the United States, continuing her postgraduate training in 1984, completing a pediatric residency at Beth Israel Medical Center in 1987 and an allergy and immunology fellowship at Montefiore and Einstein in 1989.
</p><p>Dr. Shliozberg&rsquo;s research focus includes food allergy, HAE, chronic sporadic urticaria, study in pediatric asthma, HIV and severe combined immunodeficiency and eosinophilic esophagitis. She is principal investigator on the use of Dupixent for pediatric patients, and has a study on AIR Supra use in children. Dr. Shilozberg has shared her work through peer-reviewed journals, book chapters, abstracts, posters and case reports and she has presented internationally and nationally. She has trained more than 70 fellows, many residents and medical students throughout her career.
</p><p>Dr. Shliozberg is board certified by the American Board of Allergy and Immunology. She is a Fellow of the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Dr. Shliozberg is a member of the American Association of Certified Allergists, the New York Allergy Society, and the Clinical Immunology Society.

</p>

Is Open Scheduling

On

Zocdoc Link

Elizabeth D. Romney

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Elizabeth

Last Name

Romney

NPI

1063892818

Faculty ID

16559

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

52626

Is Open Scheduling

On

Zocdoc Link

Elina Jerschow

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/a30332f0-90bc-11ec-8b8b-65ee0339d1f6.jpg

First Name

Elina

Last Name

Jerschow

NPI

1922197235

Faculty ID

11706

CMO Specialties

Clinical Terms

Employment Status

Voluntary

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><a href="http://www.superdoctors.com/new-york-metro/doctor/Elina-Jerschow/cc8605…; target="_blank" rel="noopener"><img class="imgNoBorderRightTop" src="/uploadedImages/departments/medicine/Faculty/jerschow-superdoctors.jpg" alt="Dr. Elina Jershow at SuperDoctors" /></a>Dr. Elina Jerschow is a Professor of Medicine (<a href="/departments/medicine/divisions/allergy-immunology/">Allergy and Immunology</a>) and an attending physician for pediatric and adult allergy and immunology at Einstein/Montefiore.&nbsp;</p>
<p>After completing her fellowship, Dr. Jerschow joined Merck &amp; Co., Inc. as an associate director in the Department of Clinical Immunology. During the work at Merck, her main research focused on the evaluation of adverse drug reactions in study participants and on developing new therapeutic targets in the area of immunology.</p>
<p>After returning to the Einstein/Montefiore Department of Medicine, Dr. Jerschow established a Center for <span style="text-decoration: underline;"><a href="https://www.einstein.yu.edu/departments/medicine/divisions/allergy-immu…; target="_blank" rel="noopener">AERD and Drug Allergy</a></span>. She is providing continuous care to patients with AERD and allergies to medications. She has also been selected as New York Times Super Doctor and NY Top Doctor for several years.</p>
<p>Dr. Jerschow&rsquo;s current research goals include the following:</p>
<ul>
<li>"Dr. Jerschow&rsquo;s current research goals are directed at the understanding of&nbsp;the role of&nbsp;nasal polyps and the&nbsp;impact&nbsp;of the&nbsp;immune cell subsets in polyp tissue on AERD severity.</li>
</ul>
<p><img class="imgNoBorderLeftTop" src="/images/faculty/ny-doctor-badge-2019.jpg" alt="Dr. Elina Jershow Top Doctor 2019" /></p>
<h3>Media Coverage</h3>
<p><a title="Diagnosis: A Runner Suddenly Developed Asthma" href="https://www.nytimes.com/2019/12/12/magazine/aspirin-exacerbated-respira…: A Runner Suddenly Developed Asthma. It Was Stranger Than It Seemed</a>&nbsp;New York Times, Dec. 12, 2019</p>
<p><a href="https://www.aaaai.org/global/latest-research-summaries/New-Research-fro…; target="_blank" rel="noopener">Nasal Polypectomy Is Associated With Reduction In Aspirin Sensitivity In AERD</a>&nbsp;2019</p>
<p><a href="https://www.aaaai.org/professional-education-and-training/podcasts">Del… Penicillin Allergies Through Oral Challenges</a>&nbsp;2019&nbsp;</p>
<p><a href="https://static.nytimes.com/email-content/RU_sample.html&quot; target="_blank" rel="noopener">Explaining Your Running Habit on Vacation. Comments on running during allergy season</a>&nbsp;New York Times, 2018&nbsp;</p>
<p><a href="https://medicalresearch.com/author-interviews/asthma-risk-varies-among-…; target="_blank" rel="noopener">Asthma Risk Varies Among Hispanic Groups After Relocation to the US</a>&nbsp;2017</p>
<p><a href="https://consumer.healthday.com/respiratory-and-allergy-information-2/as…; target="_blank" rel="noopener">Poor Asthma Sufferers Often Stuck in Homes That Worsen Their Disease</a>&nbsp;2017</p>
<p><a href="http://www.medpagetoday.com/MeetingCoverage/AAAAI/56643&quot; target="_blank" rel="noopener">Treatment of Aspirin Exacerbated Respiratory Disease in Minorities</a>&nbsp;2017</p>
<p><strong>Fatal anaphylaxis in the U.S. 2014</strong></p>
<p>Editor&rsquo;s pick for featuring in The Editor&rsquo;s Choice of the J Allergy Clin Immunology. Also featured in the New Research section of the American Academy of Allergy, Asthma and Immunology <a href="https://www.aaaai.org/global/latest-research-summaries/Current-JACI-Res…; target="_blank" rel="noopener">website</a></p>
<p>Also cited by major media companies, including The New York Times, US News, Medscape, etc.</p>
<ul>
<li><a href="http://well.blogs.nytimes.com/2014/10/06/drugs-cause-most-fatal-allergi…; target="_blank" rel="noopener">New York Times</a></li>
<li><a href="http://health.usnews.com/health-news/patient-advice/articles/2014/11/19…; target="_blank" rel="noopener">US News</a></li>
<li><a href="http://consumer.healthday.com/respiratory-and-allergy-information-2/mis…; target="_blank" rel="noopener">HealthDay</a></li>
<li><a href="http://www.medscape.com/viewarticle/832749">http://www.medscape.com/vie…;
</ul>
<p><strong>Dichlorophenols and allergies 2012</strong></p>
<p>Editor&rsquo;s pick for press release</p>
<p>Also cited by major media companies, including CNN, Time, Telegraph, Discovery, Voice of America</p>
<ul>
<li><a href="http://healthland.time.com/2012/12/03/study-links-food-allergies-to-pes…; target="_blank" rel="noopener">Time</a></li>
<li><a href="http://thechart.blogs.cnn.com/2012/12/04/pesticides-in-tap-water-produc…; target="_blank" rel="noopener">CNN.com</a></li>
<li><a href="http://www.telegraph.co.uk/news/health/news/9717546/Water-purifier-chem…; target="_blank" rel="noopener">Telegraph</a></li>
<li><a href="http://www.cbsnews.com/news/pesticides-in-tap-water-linked-to-food-alle…; target="_blank" rel="noopener">CBS News</a></li>
<li><a href="http://www.voanews.com/content/pesticide-suspected-in-rising-food-aller…; target="_blank" rel="noopener">VOA News</a></li>
<li><a href="http://www.foxnews.com/health/2012/12/04/are-pesticides-and-food-allerg…; target="_blank" rel="noopener">Fox News</a></li>
<li><a href="http://abcnews.go.com/blogs/health/2012/12/03/pesticides-in-tap-water-l…; target="_blank" rel="noopener">ABC News</a></li>
</ul>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p><strong>Selected publications:</strong></p>
<ol>
<li><strong>Jerschow E.,&nbsp;</strong>Edin M.L., Chi Y., Hurst B., Abuzeid W.M., Akbar N.A., Gibber M., Fried M., Han W., Pelletier T., Z. Ren, Keskin T., Roizen Gottlieb G., Lih F.B., Gruzdev A., Bradbury J.A., Schuster V., Spivack S., RosenstreichD, Zeldin D.C. Sinus surgery is associated with a decrease in aspirin-induced reaction severity in AERD patients. J Allergy Clin Immunol: In Practice, 2019. PMID: 30580047&nbsp;<em>Editor&rsquo;s pick for featuring in the New Research section of the AAAAI website and for Practice Matters section of JACI in Practice. This study was also featured in an <a href="https://www.jaci-inpractice.org/article/S2213-2198(19)30310-1/fulltext&…; target="_blank" rel="noopener">Editorial</a>.</em></li>
<li>Pelletier T., Roizen G., Ren Z., Hudes G., Rosenstreich D.,&nbsp;<strong>Jerschow E.</strong>&nbsp;Comparable safety of two aspirin desensitization protocols for aspirin-exacerbated respiratory disease (AERD). The Journal of Allergy and Clinical Immunology: In Practice, 2018, PMID: 30144584</li>
<li>Feldman JM, Zeigler AE, Nelson K, Morales E, Pelletier T, Roizen Gottlieb G, Ren Z.,&nbsp;<strong>Jerschow E.</strong>&nbsp;Depression symptoms and quality of life among individuals with Aspirin-Exacerbated Respiratory Disease. J Asthma, 2018, PMID: 29972652</li>
<li>Iammatteo M., Alvarez-Arango, S., Ferastraoaru D., Akbar N., Lee A.Y., Cohen H.W.,&nbsp;<strong>Jerschow E.</strong>&nbsp;Safety and Outcomes of Oral Graded Challenges to Amoxicillin without Prior Skin Testing. The Journal of Allergy and Clinical Immunology: In Practice, 2018. PMID: 29802906.&nbsp;<em>Editor&rsquo;s pick for featuring in the New Research section of the American Academy of Allergy, Asthma and Immunology website</em></li>
<li><strong>Jerschow E.,&nbsp;</strong>Edin M.L., Pelletier T., Abuzeid W.M., Akbar N.A., Gibber M., Fried M., Lih F.B., Gruzdev A., Bradbury J.A., Han W., Hudes G., Keskin T., Schuster V., Spivack S., Zeldin D.C., RosenstreichD. Plasma 15-hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol: In Practice. 2017 PMID: 28159558</li>
<li>Scaperotti M., Gil N., Downs I., Jeyakuma A., Liu A., MD, Chan J., Bonner J., Kelly M.S., Nosanchuk J.D., Cohen H.W.,<strong>&nbsp;Jerschow E.&nbsp;</strong>Development and evaluation of a web-based dermatology teaching tool for preclinical medical students. MedEdPortal for Association of American Medical Colleges (AAMC) 2017&nbsp;<a href="https://www.mededportal.org/publication/10619/">https://www.mededportal… Editor&rsquo;s Choice for Exemplary Educational Resource</em></li>
<li><strong>Jerschow E.</strong>, Lin R.Y., Scaperotti M., McGinn A.P. Fatal anaphylaxis in the United States 1999-2010: temporal patterns and demographic associations. J Allergy Clin Immunol 2014, 134(6):1318-1328. PMID: 25280385.&nbsp;<em>Editor&rsquo;s pick for featuring in The Editor&rsquo;s Choice of the J Allergy Clin Immunology and in the New Research section of the American Academy of Allergy, Asthma and Immunology website</em></li>
</ol>

EMR ID

4409

Is Open Scheduling

Off

Sameen Farooq

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Sameen

Last Name

Farooq

NPI

1912391822

Faculty ID

16635

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

76398

Is Open Scheduling

Off

Larry Jay Bernstein

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/bc663170-af93-11ec-86ad-cb95d1303b53.jpeg

First Name

Larry

Last Name

Bernstein

NPI

1851380950

Faculty ID

963

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

3195

Biography

<p>Larry J. Bernstein, MD, is Associate Program Director, Allergy and Clinical Immunology at the Children&rsquo;s Hospital at Montefiore Einstein and Associate Clinical Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Bernstein&rsquo;s clinical focus is in chronic urticaria, asthma, and primary and acquired immunodeficiencies.</p><p>After receiving his Bachelor of Arts from Yeshiva University in 1973, Dr. Bernstein came to Einstein for his medical education, earning his Doctor of Medicine in 1977. He completed his internship and residency in pediatrics at Bronx Municipal Hospital Center in 1981, taking on the role of Chief Resident in his final year. In 1983, Dr. Bernstein completed a two-year fellowship in allergy and immunology at Einstein.</p><p>Dr. Bernstein&rsquo;s research focus is in clinical service grants for HIV care. He has shared his work through peer-reviewed journals, abstracts, poster presentations and book chapters.</p><p>Dr. Bernstein is a Diplomate of the American Board of Pediatrics and the American Board of Allergy and Immunology. He is a Fellow of the American College of Allergy and Immunology and a member of the American Academy of Allergy and Immunology and the Clinical Immunology Society. In 1981, he received the Leo M. Davidoff Certificate of Distinction for excellence in medical student teaching.</p>

Is Open Scheduling

On

Zocdoc Link

Nomeda Balcetis

https://assets.montefioreeinstein.org/profiles/images/physphoto/BALCETIS-Nomeda_420x504.jpg

First Name

Nomeda

Last Name

Balcetis

NPI

1508843756

Faculty ID

16542

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

83171

Is Open Scheduling

Off

Matthew J. Akiyama

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/a703c590-85e5-11ec-a5a4-39080ebc53e5.jpg

First Name

Matthew

Last Name

Akiyama

NPI

1316259419

Faculty ID

14789

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Akiyama is an Associate Professor of Medicine and Clinician-Investigator in the Divisions of General Internal Medicine and Infectious Diseases. In addition to providing care and treatment to people living with HIV, hepatitis C virus (HCV), and substance use disorders, Dr. Akiyama conducts research focusing on HCV among socioeconomically marginalized populations with particular emphasis on the intersection of HCV in the criminal legal system and sub-Saharan Africa. Dr. Akiyama is the recipient of a K99/R00 award from the National Institute on Drug Abuse to develop and test an innovative strategy to improve linkage to and retention in HCV treatment among individuals recently released from jail. He is also the recipient of an Avenir Award from the National Institute on Drug Abuse focused on HCV Transmission Networks Among People Who Inject Drugs.&nbsp;</p>
<p>Dr. Akiyama&nbsp;completed his Infectious Diseases Fellowship at New York University/Bellevue Hospital Center and a Master of Science in Medical Anthropology at University College London in London, England.&nbsp;</p>
<p><strong>Selected Awards</strong>&nbsp;<strong>&amp; Honors</strong></p>
<p>Recipient, Justice Community Opioid Innovation Network LEAP Investigator Scholarship (2020)</p>
<p>Member, New York State Governor's Hepatitis C Elimination Task Force (2018)</p>
<p>Albert Einstein College of Medicine KL2 Career Development Award (2017)</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Provide care and treatment to people living with and at risk for HIV, viral hepatitis, and substance use disorders.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Conduct research focusing on HIV and viral hepatitis.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<div class="cit">
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"><strong>Akiyama MJ</strong>, Spaulding AC, Nijhawan AE.&nbsp;Long-Acting Injectable Antiretrovirals in Incarcerated Populations - Challenges and Opportunities.&nbsp;</span></span><span style="font-family: Calibri, sans-serif; font-size: 16px;">N Engl J Med. 2</span><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">022 Nov 10;387(19):1728-1730.</span></span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Kronfli N, Cabezas J, Sheehan Y, Thurairajah PH, Lines R, Lloyd AR; International Network on Health and Hepatitis in Substance Users&ndash;Prisons Network.&nbsp;Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.&nbsp;Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong><span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">, Muller A, Huang O, Lizcano J, Nyakowa M, Riback L, Ross J, Bundi H, Kulabi ES, Mwangi AM, Musyoki H, Cherutich P, Kurth A.</span> Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya: A qualitative study. <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Glob Public Health. 2021 Mar 9:1-13.</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Spaulding AC, Rich JD. Flattening the Curve for Incarcerated Populations - Covid-19 in Jails and Prisons. N Engl J Med.&nbsp;2020 May 28;382(22):2075-2077.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Lipsey D,^&nbsp;Ganova-Raeva L, Punkova L, Agyemang L, Sue A, Ramachandran S, Khudyakov Y, Litwin AH. A Phylogenetic Analysis of HCV Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.&nbsp;J Infect Dis. 2020 Mar 9.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Cleland CM, Lizcano J, Cherutich P, Kurth A. Hepatitis C Prevalence, Estimated Incidence, Risk Behaviors, and Genotypic Distribution Among People Who Inject Drugs Accessing Harm Reduction Services in Kenya: A Retrospective Cohort Study. Lancet ID.&nbsp;2019 Nov;19(11):1255-1263.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Columbus D, MacDonald R, Jordan AO, Schwartz J, Litwin AH, Eckhardt B, Carmody E.&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pubmed/31395019"><span style="color: black;">Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial.</span></a>&nbsp;BMC Infect Dis. 2019 Aug 8;19(1):703.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Norton BL, Arnsten JH, Agyemang L, Heo M, Litwin AH.&nbsp;Intensive&nbsp;Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy.&nbsp;Annals of Internal Medicine.&nbsp;2019 Apr 9.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">Spaulding AC, Graham CS,&nbsp;<strong>Akiyama MJ</strong>, Chhatwal J, Nijhawan AE, Ninburg MH, Rich JD, Strick LB, Taylor LE, Trooskin SB, Westergaard RP, Sabol WJ. HCV prevalence estimates among incarcerated persons.&nbsp;Hepatology. 2019 Apr 2.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">Norton BL,&nbsp;<strong>Akiyama MJ</strong>, Zamor PJ, Litwin AH.&nbsp;Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice. Infect Dis Clin North Am. 2018 Jun;32(2):347-370.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Feffer R, Von Oehsen III WF, Litwin AH. Drug Purchasing Strategies to Treat People With Hepatitis C in the Criminal Justice System<strong>.&nbsp;</strong>AJPH. 2018 May;108(5):607-608.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Agyemang L, Arnsten, JH, Heo M, Norton BL, Schackman BR, Linas BP, Litwin AH.&nbsp;Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.&nbsp;BMC Infect Dis. 2018 Feb 9;18(1):74.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">MacDonald R,&nbsp;<strong>Akiyama MJ</strong>, Kopolow A, Rosner Z, McGahee W, Joseph R, Jaffer M, Venters H. Full Title: Feasibility of Treating Hepatitis C in a Transient Jail Population. Open Forum Infect Dis.&nbsp;2017 Jul 7;4(3):ofx142.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Kaba F, Rosner Z, Alper H, Kopolow A, Litwin A, Venters H, Macdonald R. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System: Epidemiologic Patterns and Priorities for Action. Public Health Reports.&nbsp;2017 Jan/Feb;132(1):41-47.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Kaba F, Rosner Z, Alper H, Holzman RS, MacDonald R. Hepatitis C Screening of the &ldquo;Birth Cohort&rdquo; (b. 1945-1965) and younger inmates of New York City Jails.&nbsp;AJPH.&nbsp;2016 Jul;106(7):1276-7.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">Feller DJ,&nbsp;<strong>Akiyama MJ</strong>, Gordon P, Agins BD. Readmissions in HIV-infected Inpatients: A Large Cohort Analysis.&nbsp;JAIDS.&nbsp;2016 Apr 1;71(4):407-12.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">BardfieldJ, Agins B,&nbsp;<strong>Akiyama MJ</strong>, Mutandi G, Basenero A, Luphala P, Kaindjee-tjituka F, Natanael S, Hamunime N. A Quality Improvement Approach to Capacity Building in Low- and Middle-Income Countries: The case of HEALTHQUAL International. AIDS.&nbsp;2015 Jul;29 Suppl2:S179-86. &nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">Vo PK, Vutien P,&nbsp;<strong>Akiyama MJ</strong>, Vu VD, Ha NB, Piotrowski JI, Wantuck J, Roytman MM, Tsai N, Cheung R, Li J, Nguyen MH. Poor Sustained Virologic Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. Digestive Diseases and Sciences 2015 Apr;60(4):1045-51.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Piotrowski JI, Roytman MM, Chan A, Hong LK, Huddleston L, Trujillo R, Tsai N. New Triple Therapy for Chronic Hepatitis C: Real Life Clinical Experience in a Community Setting. Hawaii Journal of&nbsp;Medicine and Public Health 2013 Sep;72(9 Suppl 4):6-13.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>
</div>

EMR ID

78529

Is Open Scheduling

On